KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Change in Cash (2016 - 2025)

LifeMD (LFMD) has disclosed Change in Cash for 14 consecutive years, with $13.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash rose 603.44% year-over-year to $13.0 million, compared with a TTM value of $1.8 million through Dec 2025, down 4.13%, and an annual FY2025 reading of $1.8 million, down 4.13% over the prior year.
  • Change in Cash was $13.0 million for Q4 2025 at LifeMD, up from -$12.4 million in the prior quarter.
  • Across five years, Change in Cash topped out at $31.9 million in Q4 2021 and bottomed at -$16.2 million in Q1 2022.
  • Average Change in Cash over 5 years is $1.4 million, with a median of $1.2 million recorded in 2024.
  • Peak annual rise in Change in Cash hit 18546.01% in 2021, while the deepest fall reached 1472.52% in 2021.
  • Year by year, Change in Cash stood at $31.9 million in 2021, then tumbled by 105.89% to -$1.9 million in 2022, then skyrocketed by 1050.99% to $17.9 million in 2023, then tumbled by 114.46% to -$2.6 million in 2024, then skyrocketed by 603.44% to $13.0 million in 2025.
  • Business Quant data shows Change in Cash for LFMD at $13.0 million in Q4 2025, -$12.4 million in Q3 2025, and $1.8 million in Q2 2025.